Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person1
VOLITIONRX LTD
Company
Primary record13
VOLITIONRX LTD filed 8-K
Item 1.01 Entry into a Material Definitive Agreement . As previously reported, VolitionRx Limited (the “ Company ”) and Lind Global Asset Management XII LLC (“ Lind ”) entered into a Securities Purchase Agreement, dated
VOLITIONRX LTD filed 4
SEC form 4 filed by VOLITIONRX LTD (CIK 93314) on 2026-10-23.
VOLITIONRX LTD filed 8-K
Item 3.02 Unregistered Sales of Equity Securities Conversions of Note As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the SPA
VOLITIONRX LTD filed SCHEDULE 13D/A
on September 4, 2026 (the "Schedule 13D"). Capitalized terms used but not defined in this Amendment have the meanings given to them in the Schedule 13D. Except as specifically amended by this Amendment, the Schedule 13D
VOLITIONRX LTD filed 8-K
Item 3.02 Unregistered Sales of Equity Securities Conversions of Notes As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “S
VOLITIONRX LTD filed 8-K
Item 8.01. Other Events . Note Prepayment As previously reported, VolitionRx Limited (the “Company”) and Lind Global Asset Management XII LLC (“Lind”) entered into a Securities Purchase Agreement, dated May 15, 2025, as
VOLITIONRX LTD filed SCHEDULE 13D
, as amended. The Reporting Persons previously reported their beneficial ownership of the Common Stock on Schedule 13G pursuant to Rule 13d-1(b), most recently by Amendment No. 6 thereto filed on August 14, 2026. This Sc
VOLITIONRX LTD filed 8-K
Item 3.02 Unregistered Sales of Equity Securities As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limi
VOLITIONRX LTD filed 8-K
Item 1.01. Entry into a Material Definitive Agreement . As previously reported, VolitionRx Limited (the “Company”) and Lind Global Asset Management XII LLC (“Lind”) entered into a Securities Purchase Agreement, dated May
VOLITIONRX LTD filed 8-K
Item 3.02 Unregistered Sales of Equity Securities As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limi
VOLITIONRX LTD filed SCHEDULE 13G/A
on July 10, 2026. As a result of the foregoing, for purposes of Reg. Section 240.13d-3, the Reporting Person beneficially owns 1,627,005 shares of Common Stock, including shares of Common Stock underlying warrants held i
VOLITIONRX LTD filed 8-K
Item 2.02. Results of Operations and Financial Condition. The following information, including Exhibit 99.1, is being “furnished” in accordance with General Instruction B.2. of Form 8-K and shall not be deemed “filed” fo
VOLITIONRX LTD filed 8-K
Item 3.02 Unregistered Sales of Equity Securities As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limi